Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chantana Polprasert

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Clinical Case Reports|August 25, 2020
Cold agglutinin disease following SARS-CoV-2 and <i>Mycoplasma pneumoniae</i> co-infectionsChatphatai Moonla, Phandee Watanaboonyongcharoen, Gompol Suwanpimolkul, et al.
Orphanet Journal of Rare Diseases|November 13, 2024
Characteristics and therapeutic outcomes of subcutaneous panniculitis-like T-cell lymphoma with and without germline HAVCR2 mutations in Thai children and adolescentsPimpitcha Youthong, Samart Pakakasama, Patcharee Komvilaisak, et al.
Acta Haematologica|March 2, 2022
Expression of Programmed Cell Death-1 and Programmed Cell Death Ligands in Nodal Peripheral T-Cell Lymphoma: Expression Pattern and Potential Prognostic RelevanceThiti Asawapanumas, Nichthida Tangnantachai, Narittee Sukswai, et al.
The American Journal of Surgical Pathology|November 18, 2015
Angioimmunoblastic T-cell Lymphomas With the RHOA p.Gly17Val Mutation Have Classic Clinical and Pathologic FeaturesSarah L Ondrejka, Bartosz Grzywacz, Juraj Bodo, et al.
Journal of Clinical Pathology|May 22, 2024
Prevalence and clinical outcomes of germline variants among patients with myeloid neoplasmsSunisa Kongkiatkamon, Pimjai Niparuck, Thanawat Rattanathammethee, et al.
Hematology (Amsterdam, Netherlands)|June 29, 2022
Genetic mutations associated with blood count abnormalities in myeloid neoplasmsChantana Polprasert, Sunisa Kongkiatkamon, Pimjai Niparuck, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 29, 2021
Excellent Prognosis of Low-Risk Myelodysplastic Syndromes (MDS) Without Detectable Myeloid-Related MutationsChantana Polprasert, Pimjai Niparuck, Thanawat Rattanathammethee, et al.
Leukemia Research|November 2, 2019
Better survivals in adolescent and Young adults, compared to adults with acute lymphoblastic leukemia - A multicenter prospective registry in Thai populationWasithep Limvorapitak, Weerapat Owattanapanich, Eakkapol Utchariyaprasit, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 18, 2022
Characteristics and Outcomes of Secondary Acute Myeloid Leukemia and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Multicenter Study From the Thai Acute Leukemia Study GroupChantiya Chanswangphuwana, Chantana Polprasert, Weerapat Owattanapanich, et al.
Hematology (Amsterdam, Netherlands)|March 23, 2023
Does leukocytosis remain a predictive factor for survival outcomes in patients with acute promyelocytic leukemia receiving ATRA plus a chemotherapy-based regimen? A prospective multicenter analysis from TALWGSmith Kungwankiattichai, Weerapat Owattanapanich, Thanawat Rattanathammethee, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Clinical Case Reports|August 25, 2020
Cold agglutinin disease following SARS-CoV-2 and <i>Mycoplasma pneumoniae</i> co-infectionsChatphatai Moonla, Phandee Watanaboonyongcharoen, Gompol Suwanpimolkul, et al.
Orphanet Journal of Rare Diseases|November 13, 2024
Characteristics and therapeutic outcomes of subcutaneous panniculitis-like T-cell lymphoma with and without germline HAVCR2 mutations in Thai children and adolescentsPimpitcha Youthong, Samart Pakakasama, Patcharee Komvilaisak, et al.
Acta Haematologica|March 2, 2022
Expression of Programmed Cell Death-1 and Programmed Cell Death Ligands in Nodal Peripheral T-Cell Lymphoma: Expression Pattern and Potential Prognostic RelevanceThiti Asawapanumas, Nichthida Tangnantachai, Narittee Sukswai, et al.
The American Journal of Surgical Pathology|November 18, 2015
Angioimmunoblastic T-cell Lymphomas With the RHOA p.Gly17Val Mutation Have Classic Clinical and Pathologic FeaturesSarah L Ondrejka, Bartosz Grzywacz, Juraj Bodo, et al.
Journal of Clinical Pathology|May 22, 2024
Prevalence and clinical outcomes of germline variants among patients with myeloid neoplasmsSunisa Kongkiatkamon, Pimjai Niparuck, Thanawat Rattanathammethee, et al.
Hematology (Amsterdam, Netherlands)|June 29, 2022
Genetic mutations associated with blood count abnormalities in myeloid neoplasmsChantana Polprasert, Sunisa Kongkiatkamon, Pimjai Niparuck, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 29, 2021
Excellent Prognosis of Low-Risk Myelodysplastic Syndromes (MDS) Without Detectable Myeloid-Related MutationsChantana Polprasert, Pimjai Niparuck, Thanawat Rattanathammethee, et al.
Leukemia Research|November 2, 2019
Better survivals in adolescent and Young adults, compared to adults with acute lymphoblastic leukemia - A multicenter prospective registry in Thai populationWasithep Limvorapitak, Weerapat Owattanapanich, Eakkapol Utchariyaprasit, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 18, 2022
Characteristics and Outcomes of Secondary Acute Myeloid Leukemia and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Multicenter Study From the Thai Acute Leukemia Study GroupChantiya Chanswangphuwana, Chantana Polprasert, Weerapat Owattanapanich, et al.
Hematology (Amsterdam, Netherlands)|March 23, 2023
Does leukocytosis remain a predictive factor for survival outcomes in patients with acute promyelocytic leukemia receiving ATRA plus a chemotherapy-based regimen? A prospective multicenter analysis from TALWGSmith Kungwankiattichai, Weerapat Owattanapanich, Thanawat Rattanathammethee, et al.
Pageof 5